TMCI Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Treace Medical Concepts Inc (TMCI) is not a strong buy at the moment for a beginner investor with a long-term focus. The stock shows weak financial performance, mixed analyst ratings, and no significant positive catalysts. Additionally, technical indicators are not strongly favorable, and there are no proprietary trading signals to support a buy decision. It is better to hold off on investing in this stock until there are clearer signs of growth or positive momentum.
The MACD is slightly positive and expanding, which is a mild bullish indicator. However, the RSI is neutral at 37.077, and the moving averages are bearish (SMA_200 > SMA_20 > SMA_5). The stock is currently trading below the pivot level of 1.341, with key support at 1.217 and resistance at 1.465. Overall, the technical indicators suggest a weak trend with no strong buy signal.
No significant positive catalysts identified. The MACD is slightly positive, and the stock has an 8.04% chance of increasing in the next month based on similar candlestick patterns.
Weak financial performance in Q4 2025, with revenue dropping by 9.01% YoY and gross margin slightly declining. Analyst ratings are mixed, with lowered price targets and concerns about growth re-acceleration. No significant insider, hedge fund, or congress trading activity. No recent news to drive positive sentiment.
In Q4 2025, revenue dropped by 9.01% YoY to $62.52M. Net income improved significantly to -$9.39M (up 1775.05% YoY), and EPS increased to -0.15 (up 1400.00% YoY). However, gross margin slightly declined to 80.62%. While there are some improvements in profitability metrics, the overall financial performance remains weak.
Analysts have mixed ratings on TMCI. Lake Street maintains a Buy rating with a reduced price target of $7, citing favorable risk-reward for patient investors. UBS and Truist have Neutral and Hold ratings, respectively, with lowered price targets of $2.25 and $2. Truist highlights concerns about growth re-acceleration and negative mix shift impacts.
